Blog

Mar 22, 2018

Nebula Genomics

Posted by in categories: biotech/medical, bitcoin

Pharma and biotech companies spend billions of dollars each year to acquire genomic data. Scientists need large genomic datasets to identify causes of disease and develop cures. However, growth of the genomic data market is hindered by small data quantities, data fragmentation, lack of data standardization and slow data acquisition.

Nebula Genomics will leverage blockchain technology to eliminate the middleman and empower people to own their personal genomic data. This will effectively lower sequencing costs and enhance data privacy, resulting in growth of genomic data. Our open protocol will leverage the genomic data growth by enabling data buyers to efficiently aggregate standardized data from many individuals and genomic databanks.

Read more

Comments are closed.